Hyperammonaemia without portal systemic shunting does not resemble hepatic encephalopathy

Advances in Experimental Medicine and Biology

Volumn 420, Issue , 1997, Pages 173-183

  Chamuleau, Robert A F M ^a   Vogels, Birgit A P M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; GLUTAMATE AMMONIA LIGASE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

AMMONIA BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN WATER; CLINICAL FEATURE; CONFERENCE PAPER; HEPATIC ENCEPHALOPATHY; HYPERAMMONEMIA; NONHUMAN; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030766361     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5945-0_11     Document Type: Conference Paper

References (37)

1. Butterworlh RF, Giguère JF, Michaud J, Lavoie J, Pomier Layrargues G. Ammonia: Key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987; 6:1-12.
2. Popken RJ, Kropveld D, Oosting J, Chamuleau RAFM. Qualitative analysis of EEG power density spectra in experimental hepatic encephalopathy. Neuropsychobiol 1983; 9:235-43.
3. Huizenga JR, Gips CH. Determination of blood ammonia using Ammonia Checker. Ann Clin Biochem 1983; 20: 187-9.
4. Van Eijk HMH, van der Heyden MAH, van Berlo CLH and Soeters PB. Fully automated liquid Chromatographic determination of amino acids. Clin Chem 1988; 34:2510-3.
5. Boer GJ, van der Woude TP, Kruisbrink J, van Heerikhuize J. Successful ventricular application of the miniaturized controlled-delivery Accurel technique for sustained enhancement of cerebrospinal fluid peptide levels in the rat. J Neusoci Meth 1984; 11:281-9.
6. Swain MS, Bergeron M, Audet R, Blei AT, Butterworth RF. Monitoring of neurotransmitter amino acids by means of an indwelling cisterna magna catheter: A comparison of two rodent models of fulminant liver failure. Hepatology 1992; 16:1028-35.
7. James JH, Jeppsson B, Ziparo V, Fischer JE. Hyperammonemia, plasma amino acid imbalance, and blood-brain barrier amino acid transport: A unified theory of portal-systemic encephalopathy. Lancet 1979; 13:772-5.
8. Fischer JE, Baldessarini RJ. False neurotransmitters and hepatic failure. Lancet 1971;2:75-80.
9. Jeppsson B, James JH, Edwards LL, Fischer JE. Relationship of brain glutamine and brain neutral amino acid concentrations after portacaval anastomosis in rats. Eur J Clin Invest 1985; 15:179-87.
10. Takahashi H, Koehler RC, Brusilow SW, Traystman RJ. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. Am J Physiol 1991; 261: H825-9.
11. Norenberg MD, Bender AS. Astrocyte swelling in liver failure: Role of glutamine and benzodiazepines. Acta Neurochir 1994; 60(suppl): 24-7.
12. Rothman SM, Olney JW. Excitotoxicity and the NMDA receptor. Trends Neurosci 1987; 10: 299-302.
13. Choi DW. Glutamate toxicity in cortical cell culture is calcium-dependent. Neurosci Lett 1985; 58:293-7.
14. Chen HV, Pelligrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE Lipton SA. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 1992:12:4427-4436.
15. Herrero JF, Headly PM, Parsons CG. Memantine selectively depresses NMDA receptor-mediated responses of rat spinal neurons in vivo. Neurosci Lett 1994;165:37-40.
16. Parsons CG, Quack G, Bresink I, Baran L, Przegalinski E, Kostowski W, Krzascik P, Hartmann S, Danysz W. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology 1995; 34: 1239-1258.
17. Müller WE, Mutschler E, Riederer P. Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementia. Pharmacopsychiatry 1995; 28:113-124.
18. Kuchiwaka H, Inao S, Yamamato M, Yoshida K, Sugita K. An assessment of progression of brain edema with amino acid levels in cerebrospinal fluid and changes in electroencephalogram in an adult cat model of cold brain injury. Acta Neurochir 1994;60(s):62-64.
19. Bustos G, Abarca J, Forray MI, Gysling K, Bradberry CW, Roth RH. Regulation of excitatory amino acid release by N-methyl-D-aspartate receptors in rat striatum: in vivo microdialysis studies. BRES 1992; 585:105-15.
20. Montague PR, Gancayo CD, Winn MJ et al. Role of NO production in NMDA receptor mediated neurotransmittor release in cerebral cortex. Science 1994;263:973-977.
21. Hawkins RA, Jessy J, Mans AM, De Joseph MR. Effect of reducing brain glutamine synthesis on metabolic symptoms of hepatic encephalopathy. J Neurochem 1993; 60:1000-6.
22. Mans AM, de Joseph MR, Donald WD, Vina JR, Hawkins RA. Early establishment of cerebral dysfunction after portacaval shunting. Am J Physiol 1990; 259: E104-10.
23. Blei AT, Olafsson S, Therrien G, Butterworlh RF. Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis. Hepatology 1994; 19:1437-44.
24. Bosman DK, Deutz NEP, De Graaff AA, vd Hulst RWN, van Eijk HMH, Boveé WMMJ, Maas MAW et al. Changes in brain metabolism during hyperammonemia and acute liver failure: results of a comparative 1HNMR spectroscopy and biochemical investigation. Hepatology 1990; 12:281-90.
25. Swain M, Butterworth RF, Blei AT. Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats. Hepatology 1992; 15:449-53.
26. Mans AM, De Joseph MR, Hawkins RA. Metabolic abnormalities and grade of encephalopathy in acute hepatic failure. J Neurochem 1994; 63:1829-38.
27. De Jong CHC, Deutz NEP, Soeters PB. Cerebral cortex ammonia and glutamine metabolism in two rat models of chronic liver insufficiency-induced hyperammonemia: influence of pair-feeding. J Neurochem 1993; 60: 1047-57.
28. Benjamin AM. Control of glutaminase activity in rat brain cortex in vitro: influence of glutamate, phosphate, ammonium, calcium and hydrogen ions. Brain Res 1981; 208: 363-77.
29. Cooper AJL, Plum F. Biochemistry and physiology of brain ammonia. Physiol Rev 1987; 67:440-519.
30. Butterworth RF, Girard G, Giguère JF. Regional differences in the capacity for ammonia removal by brain following portacaval anastomosis. J Neurochem 1988; 51:486-90.
31. Girard G, Butterworth RF. Effect of portacaval anastomosis on glutamine synthetase activities in liver, brain, and skeletal muscle. Dig Dis Sci 1992; 7: 1121-6.
32. 15N NMR measurement of the in vivo rate of glutamine synthesis and utilization at steady state in the brain of the hyperammonemic rat. Biochem J 1993; 289: 461-8.
33. 15N NMR study of in vivo cerebral glutamine synthesis in hyperammonemic rats. NMR in Biomed 1993; 6: 21-6.
34. 15N heteronuclear multiple quantum coherence-transfer NMR. Biochem J 1995; 311: 681-8.
35. Krieger D, Krieger S, Jansen O, Gass P, Theilmann L, Lichtnecker H. Manganese and chronic hepatic encephalopathy. Lancet 1995; 346: 270-4.
36. Vogels BAPM, van Steynen B, Maas MAW,Jorning GGA, Chamuleau RAFM. The effects of ammonia and portal-systemic shunting on brain metabolism, neurotransmission and intracranial hypertension in hyperammonemia-induced encephalopathy. J Hepatol 1996;24:in press
37. Vogels BAPM, Maas MAW, Daalhuisen J, Quack G, Chamuleau RAFM. Memantine, a non-competitive NMDA-reccptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats. Hepatology 1996;submitted.